Vergoeding 2019-2023 voor ATC-subgroep J02AC : Triazool- en tetrazoolderivaten
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| J02AC01 Fluconazol (Diflucan ®) | 757.980 | 720.260 | 668.580 | 768.670 | 785.940 |
| J02AC02 Itraconazol (Trisporal ®) | 1.627.900 | 1.274.100 | 1.176.900 | 1.203.000 | 1.359.500 |
| J02AC03 Voriconazol (Vfend ®) | 655.340 | 559.700 | 430.040 | 338.140 | 372.330 |
| J02AC04 Posaconazol (Noxafil ®) | 6.751.400 | 5.082.600 | 3.304.100 | 3.750.200 | 4.112.300 |
| J02AC05 Isavuconazol (Cresemba ®) | 834.370 | 1.024.900 | 842.770 | 1.407.400 | 1.606.400 |
| Totaal | 10.626.990 | 8.661.560 | 6.422.390 | 7.467.410 | 8.236.470 |